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The binding of collagenase to both a*-macroglobulin and the tissue inhibitor of metalloproteinases was stud- 
ied using purified materials. Collagenase bound preferentially to az-macroglobulin although no transfer of 
collagenase to az-macroglobulin occurred if the enzyme was first mixed with the tissue inhibitor of metallo- 
proteinases. The sequences of amino acids in both inhibitors likely to be responsible for the binding of colla- 
genase are discussed and compared to the cleavage site in the collagen molecule. 
Collagenase Cleavage site Connective tissue breakdown Enzyme-inhibitor complex 
TIMP 
1. INTRODUCTION 
The enzyme collagenase is a metalloproteinase 
which specifically cleaves the triple helical collagen 
molecule at one point to give characteristic l/4 and 
3/4 fragments. This enzyme is thought to be in- 
volved in normal tissue remodelling, and conse- 
quently a number of control mechanisms exist to 
limit its extracellular activity. 
Various workers have investigated the naturally 
occurring metalloproteinase inhibitors. Using 
either cell or explant culture techniques they 
detected an inhibitor of metalloproteinases re- 
leased from the tissues or cells in the early days of 
culture [ 11. This inhibitor, named the tissue in- 
hibitor of metalloproteinases (TIMP), was subse- 
quently purified to homogeneity from rabbit bone 
culture medium [2], human tendon culture 
medium [3] and human skin fibroblast culture 
medium [4]. All these inhibitors were glycoproteins 
with an Mr of approx. 27500 and they specifically 
inhibited metalloproteinases. TIMP interacted 
with the active form of collagenase to form a tight 
binding enzyme-inhibitor complex which had an 
apparent h& of 54000. It appeared that this in- 
teraction was irreversible and the enzyme once 
bound by inhibitor could not further degrade col- 
lagen [5]. In addition, the inhibitor formed a 
similar tight-binding complex with the pro- 
teoglycanase and gelatinase purified from rabbit 
bones [6]. 
Human body fluids contain low levels of TIMP 
[7,8] and we have recently detected and purified 
this inhibitor from rheumatoid synovial fluid 
[9,10]. However, in both serum and synovial fluid 
the majority of the collagenase inhibitor activity 
(> 95%) towards collagenase is due to the presence 
of aut-macroglobulin &M) [l 11, a proteinase in- 
hibitor which can inhibit all the four classes of pro- 
teinases [12]. As both cu2M and TIMP are present 
in rheumatoid synovial fluid [9] we decided to in- 
vestigate the binding of collagenase to both in- 
hibitors. 
2. MATERIALS AND METHODS 
Ultrogel AcA 44 was obtained from LKB in- 
struments, Croydon, England. All chemicals and 
reagents were of the highest analytical grade 
available and were obtained from the suppliers 
previously described [2,5]. Collagenase was 
iodinated using the Bolton and Hunter reagent as 
described [ 131. TIMP was prepared from rabbit 
bone culture medium [2]. Collagenase was 
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Fig. 1. Gel filtration of ‘251-labelled collagenase with and without inhibitors. A sample of ‘251-labelled collagenase was 
divided into five equal portions. One was loaded onto a column of Ultrogel AcA 44 (1.6 x 88 cm) and eluted at a flow 
rate of 12 ml/h. Fractions (1.8 ml) were collected and counted for 12’1 radioactivity. The other four portions were mixed 
with equimolar amounts of (a) TIMP, (b) CYZM, (c) TIMP + CYZM, (d) TIMP followed by a2M. The elution profiles are 
shown for collagenase chromatographed with (-) and without (---) inhibitors. 
10 
Volume 209, number 1 FEBS LETTERS December 1986 
prepared from pig synovial tissue culture medium 
[ 131 and the interaction experiments of enzyme and 
inhibitor as described by Cawston et al. [5]. Col- 
lagenase activity was measured following the diges- 
tion of 14C type I collagen [14]. For collagenase 
inhibitor assays a known amount of collagenase 
was added and assayed in the presence of inhibitor 
samples. A unit of collagenase degrades 1 pg of 
collagen/min at 37°C and 1 unit of inhibitor in- 
hibits 2 units of collagenase by 50% [5]. cvzM was 
prepared by the method of Barrett [15]. 
3. RESULTS 
Collagenase is known to form a tight-binding 
complex (MT 54000) with TIMP that is stable to gel 
filtration [5]. Collagenase was labelled with 1251 
and applied to an Ultrogel AcA 44 gel filtration 
column. The ‘251-labelled peak of collagenase 
eluting at M, 30000 was pooled. Aliquots of this 
pool were then reapplied to the column both alone 
and with sufficient TIMP to just inhibit all the en- 
zyme present. In the presence of TIMP the labelled 
collagenase eluted at an M, of 54000 (fig.la). 
When an equimolar amount of sufficient a2M was 
added to the collagenase to just inhibit all the en- 
zyme a different elution profile was obtained 
(fig.lb). All of the i2%labelled collagenase luted 
at the void volume of the column indicating that it 
was bound to the large (YZM molecule. Fig.lc il- 
lustrates the results obtained when sufficient 
TIMP and (YZM each to inhibit completely the col- 
lagenase were mixed together and then the lz51- 
labelled collagenase was added to this mixture and 
subsequently gel filtered. The collagenase was 
preferentially bound to the CYZM and no peak of 
radioactivity was found at M, 54000. A subsequent 
experiment (fig. Id) mixed an equimolar portion of 
TIMP and ‘251-labelled collagenase. After incuba- 
tion at room temperature an equimolar portion of 
a2M was added and the mixture gel filtered 
(fig.ld). The profile indicates that after binding to 
TIMP the collagenase could not be transferred to 
cv2M as all of the 1251-labelled protein eluted at M, 
54000. 
4. DISCUSSION 
Previous studies on the interaction of TIMP 
with collagenase have indicated that the col- 
lagenase binds tightly and specifically to the in- 
hibitor [5]. Although Stricklin and Welgus [4] 
originally suggested that collagenase only bound 
TIMP in the presence of collagen they have recent- 
ly reported [16] that a complex, stable to gel filtra- 
tion, is rapidly formed. Other workers have also 
reported that collagenase rapidly binds to TIMP 
[3]. As TIMP appears to be produced by connec- 
tive tissue cells to control specifically the local ex- 
tracellular activity of the metalloproteinases and 
(YZM is a proteinase inhibitor in general confined to 
the bloodstream and with a broad specificity for 
all four classes of proteinases we were surprised to 
find that collagenase bound to CYZM when in com- 
petition with TIMP. The sequence of amino acids 
reported to be responsible for the binding of col- 
lagenase by cvzM was suggested to be the Gly-Pro- 
Glu-Gly-Leu sequence found close to the cleavage 
site of m2M [ 171. This resembled the Gly-Pro-Glu- 
Gly-Ile sequence at the cleavage site of the collagen 
a-chain. In TIMP no similar sequence appears to 
be present except for an Arg-Glu-Pro-Gly-Leu se- 
quence near the C-terminal end [18]. Whether or 
not this is the cleavage site or binding site for col- 
lagenase is not known but it is interesting to note 
that the corresponding sequence in TIMP is less 
homologous to the collagen cleavage site than that 
in CQM and this may be why collagenase binds 
preferentially to cuzM. 
These results differ from those reported [19] 
where human polymorphonuclear leukocyte col- 
lagenase was incubated for 24 h with a mixture of 
human plasma Bi-anticollagenase and an excess of 
human a2M. Only 10% of the collagenase bound 
to the crzM whilst the remainder was firmly bound 
to the Br-anticollagenase. However, it is not clear 
if the inhibitor described by Macartney and 
Tschesche [19] as Bi-anticollagenase is the same 
protein as TIMP [20]. 
It is apparent too from these results that the 
binding of collagenase to cw2M is rapid and it ob- 
viously occurs more quickly than the binding to 
TIMP which is known to be fast [5]. Werb et al. 
[21] reported that rather slow binding to col- 
lagenase occurred although Borth [22] reported a 
rapid binding and cleavage of the a2M to the fast 
form by collagenase. 
These results do not necessarily suggest hat azM 
has a major role in the inhibition of collagenase. It 
is likely that TIMP’s main role is in a very local 
11 
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area immediately around the cell from which, in 
connective tissue, (YZM is excluded because of its 
size. However, the results do suggest hat cu2M can 
rapidly inactivate collagenase in acute inflam- 
matory situations and so limit tissue damage. In 
order to determine the extent to which either in- 
hibitor is responsible for prevention of col- 
lagenolytic activity it would be interesting to 
analyse biological fluids for the amounts of either 
C~ZM or TIMP bound to collagenase. 
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